SCM
MRTX

Soleus Capital Management’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Soleus Capital Management’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-3,466
Closed -$594K – 83
2021
Q1 		$594K Sell
3,466
-4,372
-56% -$749K 0.11% 69
2020
Q4 		$1.72M Buy
+7,838
New +$1.72M 0.23% 40